IREN (NASDAQ: IREN) delivered eye-popping volatility in 2025, racing from low single digits to highs north of $75 before ...

Its Super Resolution component is a second-generation upgrade to the 'Transformer' upscaling model introduced with DLSS 4, ...

A new ClickFix social engineering campaign is targeting the hospitality sector in Europe, using fake Windows Blue Screen of ...

EDINBURGH, United Kingdom, Jan. 06, 2026 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”), a clinical-stage biopharmaceutical company focused on improving treatment outcomes ...

A new Python-based malware called VVS stealer has been identified, targeting Discord users with stealthy techniques to steal ...

The Dyson HushJet Compact Air Purifier is specifically designed for quieter air purification in smaller rooms, featuring a ...

Chrome extensions called "Phantom Shuttle" stole user data for years before Google removed them from the Chrome Web Store ...

NuCana plc (NASDAQ: NCNA) ("NuCana" or the "Company"), a clinical-stage biopharmaceutical company focused on improving treatment outcomes for ...

Qualcomm has made a range of announcements at CES 2026, and notably introduced the Dragonwing Q‑7790 and Q‑8750 processors ...

In M&A, the real risk is the security gap you don’t see. Close it early, or attackers and regulators will find it for you.

Eighty years after total war transformed the continent, European countries are making big bets on new instruments of ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and interdisciplinary approaches are helping to address them.